Enhanced Investments - Financial Portal

BIO-TECHNE RELEASES MITOBRILLIANT™ FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS

Published: 2022-12-05 12:00:00 ET

MINNEAPOLIS, Dec. 5, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the introduction of MitoBrilliant™ probes. These novel probes enable the fluorescent labeling and tracking of mitochondria in live and fixed cells.

Fluorescent probes that enable highly accurate, sensitive, specific and persistent labeling of mitochondria is critical for a range of demanding scientific and biomedical applications, including high-content screening, flow cytometry and super-resolution microscopy. To enhance the capabilities of modern imaging platforms used to conduct these studies, two types of MitoBrilliant™ probes have been developed targeting specific applications. MitoBrilliant™ Live probes enable longer-term, dynamic monitoring of the mitochondrial membrane potential in live cells. The fixable probe, MitoBrilliant™ 646, provides outstanding performance and resolution post-fixation. Additionally, MitoBrilliant™ 646 can be used to stain pre-fixed cells and tissue, successfully meeting the demand for a 'universal' mitochondrial probe that can fit directly into standard protocols for high-content screening and immunofluorescence.

The probes were developed using the Janelia Fluor™ fluorescent dye technology, licensed to Bio-Techne by the Howard Hughes Medical Institute, Janelia Research Campus. They confer key properties that make the Janelia Fluor dyes so widely used (such as brightness, photostability, suitability for super-resolution microscopy) into our next-generation MitoBrilliant™ probes.

"We are committed to developing innovative tools to facilitate and accelerate scientific discovery. The next-generation MitoBrilliant™ dyes represent exactly that, and we are thrilled to bring these differentiated new probes to the life sciences community" said Will Geist, President of Bio-Techne's Protein Sciences Segment. "These dyes, developed by Tocris Bioscience (a Bio-Techne brand), showcase our outstanding capabilities in synthetic chemistry and unique capabilities in fluorophore design."

About Bio-Techne

Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022 and has approximately 3,000 employees worldwide. For more information on Bio-Techne and its brands, please visit http://www.bio-techne.com.

About Bio-Techne Corporation (NASDAQ: TECH)Contact: David Clair, Vice President, Investor Relationsdavid.clair@bio-techne.com 612-656-441

View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-releases-mitobrilliant-fluorescent-dyes-providing-a-next-generation-tool-for-imaging-mitochondria-in-live-and-fixed-cells-301692896.html

SOURCE Bio-Techne Corporation

Enhanced Investments, Inc.
329 South Oyster Bay Road #2085
Plainview, NY 11803
team@eninvs.com

Important disclosures

Performance results were prepared by Enhanced Investments, and have not been compiled, reviewed or audited by an independent accountant. Performance estimates are subject to future adjustment and revision. Investors should be aware that a loss of investment is possible. Account holdings are for illustrative purposes only and are not investment recommendations. Additional information, including (i) the calculation methodology; and (ii) a list showing the contribution of each holding to the portfolio’s performance during the time period will be provided upon request.
All statements made via social media sites sponsored or maintained by Enhanced Investments and its affiliates are for informational purposes only and do not constitute a comprehensive description of Enhanced Investments' investment advisory services.
Certain investments are not suitable for all investors. Before investing, consider your investment objectives and applicable fees. The rate of return on investments can vary widely over time, especially for long term investments. Investment losses are possible, including the potential loss of all amounts invested. Information provided by Enhanced Investments is for informational and general educational purposes only and is not investment or financial advice.

Nothing on this website should be considered an offer, solicitation of an offer, or advice to buy or sell securities.
Past performance is no guarantee of future results. Any historical returns, expected returns [or probability projections] are hypothetical in nature and may not reflect actual future performance.
All the strategies assume investments in equity invstrumenta only and are more relevant for "agressive investment profile". Eastern European flagship strategy assumes using up to 20% leverage of total portfolio. GlobalCommodities and US Growth strategy currently assume no leverage.
Results for the Enhanced Investments strategies as compared to the performance of Illustrative Benchmarks is for informational purposes only. Our investment program does not mirror that of the Illustrative Benchmarks and the volatility may be materially different from the volatility of Illustrative Benchmarks. Reference or comparison to an Illustrative Benchmark does not imply that strategies of Enhanced Investments will be constructed in the same way as the Illustrative Benchmark or achieve returns, volatility, or other results similar to those of the Illustrative Benchmark. The S&P 500 is an unmanaged market capitalization-weighted index of 500 common stocks chosen for market size, liquidity, and industry group representation to represent U.S. equity performance.
Performance results were prepared by Enhanced Investments, and have not been compiled, reviewed or audited by an independent accountant. Performance estimates are subject to future adjustment and revision. Investors should be aware that a loss of investment is possible. Account holdings are for illustrative purposes only and are not investment recommendations. Additional information, including (i) the calculation methodology; and (ii) a list showing the contribution of each holding to the portfolio’s performance during the time period will be provided upon request.
All statements made via social media sites sponsored or maintained by Enhanced Investments and its affiliates are for informational purposes only and do not constitute a comprehensive description of Enhanced Investments' investment advisory services.
Certain investments are not suitable for all investors. Before investing, consider your investment objectives and applicable fees. The rate of return on investments can vary widely over time, especially for long term investments. Investment losses are possible, including the potential loss of all amounts invested. Information provided by Enhanced Investments is for informational and general educational purposes only and is not investment or financial advice.